BCPC

Balchem Corporation · NASDAQ · Basic Materials · USD · 10-K for 2025, filed 2026-02-20

Figures on this page computed 2026-11-08 12:12 UTC

Last close

179.71USD

Market data, 2026-11-05

Except where said otherwise: 10-K for 2025, filed 2026-02-20

  • 36.3xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-02-20

    The filing itself

  • 11.8%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-20
    • 10-K for 2025, filed 2026-02-20
    • 10-K for 2025, filed 2026-02-20
    • 10-Q for 2025, filed 2026-10-23
    • 10-K for 2025, filed 2026-02-20
    • 10-Q for 2025, filed 2026-10-23

    The filing itself

  • 14.9%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-20
    • 10-K for 2025, filed 2026-02-20

    The filing itself

  • n/aFCF margin

    We do not hold this figure for this company, so there is nothing to place.

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-20
    • 10-K for 2025, filed 2026-02-20
    • 10-K for 2025, filed 2026-02-20

    The filing itself

  • 0.16Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-20
    • 10-Q for 2025, filed 2026-10-23

    The filing itself

  • 0.6%Dividend yield
    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
    • computed
    • Computed from the filing for 2025, filed 2026-02-20

What it sells, to whom

lens 8 of 9

What it sells

3
Human Nutrition and Health659,387,000 USD63.9%
Animal Nutrition and Health230,852,000 USD22.4%
Specialty Products140,976,000 USD13.7%

Where it sells it

2
UNITED STATES759,448,000 USD73.2%
Non-US277,713,000 USD26.8%

Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.

3 segments, 2 places and 0 named customers, each as the filer published it.

3 segments, 2 places and 0 named customers, each as the filer published it.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-20

  • Human Nutrition and Health659,387,000
    Source
    filed
    Statement
    segments
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD

    The filing itself

  • Animal Nutrition and Health230,852,000
    Source
    filed
    Statement
    segments
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD

    The filing itself

  • Specialty Products140,976,000
    Source
    filed
    Statement
    segments
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD

    The filing itself

  • UNITED STATES759,448,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD

    The filing itself

  • Non-US277,713,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2025
    Accession
    0000009326-26-000007
    Reported in
    USD

    The filing itself

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.